Skip to content

Eton Pharmaceutical

US · ETON #2944 by market cap Listed 2018
60.85 -0.51 -0.83%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Company notice
    4: Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
    SEC · 2026/7/8
  • Company notice
    4/A: Eton Pharmaceutical | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Opaleye Management Inc.
    SEC · 2026/7/18
  • Rating change
    H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $80
    Market Newswire · 2026/11/6
  • Rating change
    Eton Pharmaceuticals (ETON) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/10/1
  • B. Riley Adjusts Price Target on Eton Pharmaceuticals to $81 From $70, Keeps Buy Rating
    MT Newswires · 2026/11/10
  • Rating change
    H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/11/3
  • Company notice
    Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Gruber James R.
    SEC · 2026/1/15
  • Rating change
    B. Riley Securities Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $81
    Market Newswire · 2026/11/10
  • Form 144 | Eton Pharmaceutical(ETON.US) Director Proposes to Sell 5.34 Million in Common Stocks
    Market Newswire · 2026/11/11
  • Rating change
    Eton Pharmaceuticals Price Target Raised to $81.00/Share From $70.00 by B. Riley Securities
    Dow Jones · 2026/11/11
  • Eton Pharmaceuticals Is Maintained at Buy by B. Riley Securities
    Dow Jones · 2026/11/11
  • Rating change
    HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target
    Benzinga · 2026/10/15
  • Rating change
    CCORF Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $68
    Market Newswire · 2026/11/3
  • Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $82
    Market Newswire · 2026/11/6
  • Rating change
    CCORF Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $68
    Market Newswire · 2026/10/15
  • Rating change
    CCORF Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $80
    Market Newswire · 2026/11/6
  • Company notice
    3: Eton Pharmaceutical | 3: Initial statement of beneficial ownership of securities- Matthews Judith M.
    SEC · 2026/6/2
  • Rating change
    Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $76
    Market Newswire · 2026/8/14
  • Company notice
    4: Eton Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.
    SEC · 2026/7/17
  • Eton Pharmaceutical(ETON.US) Director Sells US$5.35 Million in Common Stock
    Market Newswire · 2026/11/11
  • Rating change
    CCORF Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $60
    Market Newswire · 2026/7/30
  • Rating change
    B. Riley Adjusts Price Target on Eton Pharmaceuticals to $70 From $40, Maintains Buy Rating
    MT Newswires · 2026/8/14
  • Rating change
    H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/8/11
  • Rating change
    Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $62
    Market Newswire · 2026/7/28
  • Eton Pharmaceuticals And Aquestive Therapeutics Enter Exclusive U.S. License And Supply Agreement For LIBERVANT Buccal Film For Seizure Clusters In Patients With Epilepsy; Sees Commercial Availability In April 2027
    Benzinga · 2026/10/14

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.

Eton Pharmaceutical discussion 0 comments

Add a comment